Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In collaboration with Oxford University Hospitals Trust we are undertaking a large analysis of linked data to examine trends of CA125 use in primary care for suspected ovarian cancer, subsequent testing in secondary care, and the final outcomes in patients who have been tested. Our findings will inform national guidance on the use of CA125 in primary care.